Literature DB >> 120779

[Increase in activity of natural killer cells (NK cells) by serum thymic factor].

P Bardos, C Carnaud, J F Bach.   

Abstract

The serum thymic factor (FTS) and one of its structural analogues have been administered to adult normal Mice for 2 to 12 weeks. This treatment induced a significant increase in spleen cell natural killer (NK) activity, evaluated by a cytotoxicity assay against YAC cells.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 120779

Source DB:  PubMed          Journal:  C R Seances Acad Sci D        ISSN： 0567-655X


  4 in total

1.  In vivo administration of serum thymic factor (FTS) prevents EMC-D virus-induced diabetes and myocarditis in BALB/cAJcl mice.

Authors:  M Mizutani; M El-Fotoh; M Mori; K Ono; K Doi; A Awaya; Y Matsumoto; Y Matsumoto; T Onodera
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

2.  The serum thymic factor (FTS). Chemical and biological aspects.

Authors:  J M Pleau; M Dardenne; J F Bach
Journal:  Mol Cell Biochem       Date:  1981-12-04       Impact factor: 3.396

3.  Reovirus type 2-induced diabetes in mice prevented by immunosuppression and thymic hormone.

Authors:  T Onodera; T Taniguchi; K Yoshihara; S Shimizu; M Sato; T Hayashi
Journal:  Diabetologia       Date:  1990-04       Impact factor: 10.122

4.  Improvement of natural killer activity and of T cells after thymopoietin pentapeptide therapy in a patient with severe combined immunodeficiency.

Authors:  M Fiorilli; M C Sirianni; F Pandolfi; I Quinti; U Tosti; F Aiuti; G Goldstein
Journal:  Clin Exp Immunol       Date:  1981-08       Impact factor: 4.330
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.